In conclusion, this study evidenced a B-cell specific regulation of UGT2B17 expression characterized by alternative promoters regulated by pro-survival transcription factors involved in CLL progression and patient’s survival. Here, UGT2B17 is linked to B-cell chronic lymphocytic leukemia.